Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/19/2024 | Q3 2024 | -$0.03 | $0 | |||
08/14/2024 | Q2 2024 | -$0.04 | $0 | |||
03/30/2024 | Q1 2024 | $0.08 | $0 | |||
12/29/2023 | Q4 2023 | -$0.06 | $0 | |||
09/28/2023 | Q3 2023 | -$0.02 | $0 | |||
06/29/2023 | Q2 2023 | -$1.40 | $0 | |||
03/30/2023 | Q1 2023 | -$0.26 | $0 | |||
12/29/2022 | Q4 2022 | $0.05 | $0 | |||
09/28/2022 | Q3 2022 | $0.03 | $0 | |||
06/28/2022 | Q2 2022 | $0.00 | $0 | |||
03/29/2022 | Q1 2022 | -$0.00 | $0 | |||
12/29/2021 | Q4 2021 | -$0.00 | $0 | |||
09/28/2021 | Q3 2021 | $0.00 | $0 | |||
06/29/2021 | Q2 2021 | $0.00 | $0 |
The conference call for Tevogen Bio Holdings Inc.'s latest earnings report can be listened to online.
The conference call transcript for Tevogen Bio Holdings Inc.'s latest earnings report can be read online.
Tevogen Bio Holdings Inc. (:TVGNW) has a recorded net income of $0. Tevogen Bio Holdings Inc. has generated $-0.0004 earnings per share over the last four quarters.
Tevogen Bio Holdings Inc. (:TVGNW) has a price-to-earnings ratio of -41.28 and price/earnings-to-growth ratio is 0.79.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED